Suppr超能文献

尿毒症中葡萄糖不耐受的发病机制。

Pathogenesis of glucose intolerance in uremia.

作者信息

DeFronzo R A

出版信息

Metabolism. 1978 Dec;27(12 Suppl 2):1866-80. doi: 10.1016/s0026-0495(78)80005-5.

Abstract

The pathogenesis of glucose intolerance in uremia was examined with the glucose clamp technique. Hyperglycemic clamp (n = 8): The plasma glucose concentration is acutely raised and maintained at 125 mg/dl above basal levels. Under these steady state conditions the glucose infusion rate, M, equals the amount of glucose metabolized: Predialysis M averaged 4.23 +/- 0.36 mg/kg/min and increased to 7.71 +/- 0.43 postdialysis (p less than 0.001). The plasma insulin response predialysis was 90 +/- 20 microU/ml and decreased to 80 +/- 23 microU/ml following dialysis. Consequently the M/l ratio, a measure of tissue sensitivity to insulin, increased by 80% +/- 25% (p less than 0.001) but still remained less than controls (p less than 0.01). Euglycemic insulin clamp (n = 10): The plasma insulin concentration is acutely raised by 100 microU/ml and the plasma glucose concentration is held constant at the basal level. Predialysis both M (3.37 +/- 0.36 mg/kg/min) and M/l (3.56 +/- 0.33 mg/kg/min per microU/ml X 100) were significantly less than controls (p less than 0.01). Postdialysis both M and M/l increased significantly (p less than 0.01) to a mean that was not significantly different from controls. Basal hepatic glucose production (n = 6), 2.15 +/- 0.09 mg/kg/min, was similar to controls and fell (87% +/- 4%) normally during the insulin clamp. In five uremic subjects in wom insulin binding to monocytes was measured, there was no correlation with tissue sensitivity to insulin (M/l). Significant abnormalities in both growth hormone and glucagon physiology were present in uremic individuals, but no correlation with either the presence or degree of glucose intolerance was demonstrable. In conclusion, glucose intolerance is universally present in uremic subjects and results primarily from peripheral tissue insensitivity to insulin. Insulin secretion is usually enhanced in an attempt to compensate for this insulin resistance but in occasional subjects uremia also inhibits beta cell sensitivity to glucose. Hepatic glucose production is unaffected by uremia. The lack of correlation between insulin binding and tissue sensitivity to insulin suggests that the cellular mechanism accounting for the insulin resistance is probably the result of a defect in intracellular metabolism or in the glucose transport system.

摘要

采用葡萄糖钳夹技术研究了尿毒症患者葡萄糖耐量异常的发病机制。高血糖钳夹试验(n = 8):将血浆葡萄糖浓度急性升高并维持在基础水平以上125mg/dl。在这些稳态条件下,葡萄糖输注速率M等于葡萄糖代谢量:透析前M平均为4.23±0.36mg/kg/min,透析后增加至7.71±0.43(p<0.001)。透析前血浆胰岛素反应为90±20μU/ml,透析后降至80±23μU/ml。因此,M/I比值(衡量组织对胰岛素敏感性的指标)增加了80%±25%(p<0.001),但仍低于对照组(p<0.01)。正常血糖胰岛素钳夹试验(n = 10):血浆胰岛素浓度急性升高100μU/ml,血浆葡萄糖浓度维持在基础水平不变。透析前M(3.37±0.36mg/kg/min)和M/I(3.56±0.33mg/kg/min perμU/ml×100)均显著低于对照组(p<0.01)。透析后M和M/I均显著增加(p<0.01),其平均值与对照组无显著差异。基础肝葡萄糖生成(n = 6)为2.15±0.09mg/kg/min,与对照组相似,在胰岛素钳夹期间正常下降(87%±4%)。对5例尿毒症患者测定了胰岛素与单核细胞的结合情况,结果显示其与组织对胰岛素的敏感性(M/I)无相关性。尿毒症患者生长激素和胰高血糖素生理均存在显著异常,但与葡萄糖耐量异常的存在或程度均无相关性。总之,葡萄糖耐量异常普遍存在于尿毒症患者中,主要源于外周组织对胰岛素不敏感。胰岛素分泌通常会增强以试图代偿这种胰岛素抵抗,但在少数患者中尿毒症也会抑制β细胞对葡萄糖的敏感性。尿毒症不影响肝葡萄糖生成。胰岛素结合与组织对胰岛素敏感性之间缺乏相关性表明,导致胰岛素抵抗的细胞机制可能是细胞内代谢或葡萄糖转运系统缺陷的结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验